Deutsche Bank Ag\ Harvard Bioscience Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 23,666 shares of HBIO stock, worth $50,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,666

Previous 15,484 52.84%

Holding current value

$50,645

Previous $44,000 43.18%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.64 - $3.54 $21,600 - $28,964	8,182 Added 52.84%	23,666 $63,000
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $20,165 - $33,706	-7,280 Reduced 31.98%	15,484 $44,000
Q1 2024 May 15, 2024	BUY	$4.02 - $5.39 $2,524 - $3,384	628 Added 2.84%	22,764 $96,000
Q4 2023 Feb 14, 2024	BUY	$4.0 - $5.49 $2,804 - $3,848	701 Added 3.27%	22,136 $118,000
Q3 2023 Nov 09, 2023	BUY	$4.0 - $5.82 $74,756 - $108,769	18,689 Added 680.59%	21,435 $92,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $11,505 - $16,915	2,746 New	2,746 $15,000
Q2 2022 Aug 11, 2022	SELL	$3.28 - $6.42 $75,092 - $146,979	-22,894 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$5.16 - $7.14 $5,474 - $7,575	-1,061 Reduced 4.43%	22,894 $142,000
Q4 2021 Feb 11, 2022	SELL	$6.37 - $8.18 $6,217 - $7,983	-976 Reduced 3.91%	23,955 $169,000
Q3 2021 Nov 04, 2021	BUY	$6.98 - $8.47 $13,904 - $16,872	1,992 Added 8.68%	24,931 $174,000
Q2 2021 Aug 11, 2021	SELL	$5.44 - $8.4 $10,722 - $16,556	-1,971 Reduced 7.91%	22,939 $191,000
Q1 2021 May 13, 2021	SELL	$3.91 - $6.99 $9,211 - $16,468	-2,356 Reduced 8.64%	24,910 $0
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $24,231 - $36,346	8,077 Added 42.09%	27,266 $117,000
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $5,010 - $7,652	1,822 Added 10.49%	19,189 $58,000
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.14 $36,818 - $54,532	17,367 New	17,367 $54,000
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $218 - $289	-89 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $383,334 - $836,585	-241,091 Reduced 99.96%	89 $0
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $310,199 - $737,727	160,725 Added 199.77%	241,180 $481,000
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $79,125 - $125,114	-28,565 Reduced 26.2%	80,455 $346,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $46,262 - $76,340	-15,268 Reduced 12.28%	109,020 $344,000
Q3 2018 Dec 21, 2021	BUY	$5.0 - $6.65 $47,330 - $62,948	9,466 Added 8.24%	124,288 $653,000
Q3 2018 Nov 14, 2018	SELL	$5.0 - $6.65 $47,665 - $63,394	-9,533 Reduced 7.67%	114,822 $601,000
Q2 2018 Apr 21, 2020	BUY	$4.2 - $5.95 $44,730 - $63,367	10,650 Added 9.37%	124,355 $665,000
Q2 2018 Aug 14, 2018	SELL	$4.2 - $5.95 $316,549 - $448,445	-75,369 Reduced 39.86%	113,705 $606,000
Q1 2018 Oct 18, 2019	SELL	$3.3 - $5.15 $26 - $41	-8 Reduced -0.0%	189,074 $945,000
Q1 2018 May 15, 2018	BUY	$3.3 - $5.15 $547,192 - $853,952	165,816 Added 712.7%	189,082 $945,000
Q4 2017 Feb 14, 2018	BUY	$3.08 - $3.8 $31,748 - $39,170	10,308 Added 79.55%	23,266 $76,000
Q3 2017 Nov 14, 2017	BUY	$2.7 - $3.75 $34,986 - $48,592	12,958	12,958 $48,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account